Tuberous Sclerosis

Tuberous Sclerosis (TSC) is a genetic condition that causes benign tumors to develop in the brain, skin and other organs. It affects about one in every 6,000 people in the United States, and is estimated to affect about 1 million people worldwide. Symptoms of TSC can vary from person to person, but may include epilepsy, intellectual disability, skin lesions and developmental delays. Treatment of TSC is tailored to each patient, and may involve medications, dietary changes and surgery. Early diagnosis and treatment of TSC can help improve quality of life for individuals with the condition and may help reduce the risk of serious complications.

← International Journal of Multiple Sclerosis and Related Disorders

Related Articles

9 article(s) found
Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis
Full-text HTML Download PDF Download XML
Neurovascular Reactivity after Repeated Attacks in Patients with Multiple Sclerosis
Full-text HTML Download PDF Download XML
Ultraviolet B Phototherapy Intervention in Patients with Multiple Sclerosis: A Prospective, Randomized Pilot Trial
Full-text HTML Download PDF Download XML
RETRACTED: Amino Acid Imbalance in Atherosclerosis
Full-text HTML Download PDF Download XML
Comparative Analysis of Atherosclerosis Risk Factors in the Staff of the Tbilisi (Georgia) Cleaning Service
Full-text HTML Download PDF Download XML
Fragiles but Resilient. The Key Strategies to Cope with Pandemic in Persons with Multiple Sclerosis. A Controlled Web Survey
Full-text HTML Download PDF Download XML
Safety of BBIBP-CorV (Sinopharm) COVID-19 Vaccination in People With Multiple Sclerosis: A Report From Iran
Full-text HTML Download PDF Download XML
Peripheral Third Cranial Nerve Palsy in A Patient With Pediatric Form of Multiple Sclerosis
Full-text HTML Download PDF Download XML
Retraction Note: Amino Acid Imbalance in Atherosclerosis
Full-text HTML Download PDF Download XML